Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5282 Target Snapshot

Cytochrome P450 2A6 · SINGLE PROTEIN · Homo sapiens

1,322Compounds
227Assays
14Approved Drugs
2,481.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P11509. Use UniProt P11509 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P11509 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cytochrome P450 2A6 as ChEMBL target CHEMBL5282, mapped to UniProt P11509. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cytochrome P450 2A6
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5282
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P11509
Cytochrome P450 2A6
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cytochrome P450 2A6 is the right protein anchor across sources, using UniProt P11509 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCytochrome P450 2A6
UniProt AccessionP11509
Component TypeProtein
Sequence Length494 aa

Cytochrome P450 2A6

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cytochrome P450 2A6, mapped to UniProt P11509. Sequence length is 494 aa.

Mapped IDP11509
Review nameCytochrome P450 2A6
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

14
Approved
3
Phase III
3
Phase I
Assay Mix

Activity Type Distribution

IC501,403.0
KI1,059.0
KD19.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3740883 10.24 Ki 0.057 Preclinical
CHEMBL3740902 8.81 Ki 1.54 Preclinical
CHEMBL3741757 8.76 Ki 1.73 Preclinical
CHEMBL3739596 8.71 Ki 1.93 Preclinical
CHEMBL3742224 8.59 Ki 2.57 Preclinical
CHEMBL3742383 8.59 Ki 2.58 Preclinical
CHEMBL3741819 8.57 Ki 2.7 Preclinical
CHEMBL3740871 8.51 Ki 3.07 Preclinical
CHEMBL3740860 8.48 Ki 3.27 Preclinical
CHEMBL3740335 8.47 Ki 3.41 Preclinical
Distribution

pChEMBL Value Distribution

127
5.0
110
5.5
95
6.0
55
6.5
32
7.0
10
7.5
5
8.0
7
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

TRANYLCYPROMINE
CHEMBL3989843
Approved 1961
METHOXSALEN
CHEMBL416
Approved 1954
Assay Landscape

Assay Landscape

227
Total Assays
285
Tested Compounds
2
Assay Types
ADME — 201 assays, 212 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 95 148 5.6
microsome format 48 41 6.2
assay format 44 22 7.8
cell-based format 8 1 4.3
tissue-based format 5 0
cell membrane format 1 0
Binding — 26 assays, 285 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 15 120 5.5
microsome format 5 11 6.6
assay format 3 101 5.3
cell-based format 3 53 5.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine